Treatment Resistant Epilepsy and N-Acetyl Cysteine

Withdrawn before enrolling · Not applicable

Conditions studied: Autistic Disorder, Seizures, Irritability

In brief

This is a study to find out whether the dietary amino acid supplement, N-acetyl cysteine (NAC) is helpful in reducing the frequency of seizures in children with autism and comorbid epilepsy whose seizures are not responding well to usual medical treatment. The study is also looking to see if this supplement is helpful for immediate and ongoing treatment of symptoms of irritability. Additionally, this study will also look to see if certain substances in the blood that measure a specific type of stress on cells in the body can help tell us how NAC may be helping.

Key facts

Study ID
NCT02054949
Run by
Nationwide Children's Hospital
People needed
0
Starts
2013-04-01
Expected to finish
2015-01-01
Last updated by the study team
2015-10-09

Who can join

Age: 6 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.